Fujian Shengdi Pharmaceutical Co., Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Fujian Shengdi Pharmaceutical Co., Ltd.
RECRUITINGPhase 2NCT07297797
Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension
This study aims to evaluate the efficacy and safety of HRS-9563 in patients with mild to moderate hypertension, and to explore its appropriate dosage.
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Enrolling: 2341 location
Mild to Moderate Hypertension
RECRUITINGPhase 2NCT07100418
A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
The study is being conducted to evaluate the efficacy and safety of HRS-7249 for patients with hyperlipidemia, and to explore the reasonable dosage of HRS-7249 for patients with...
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Enrolling: 2001 location
Hyperlipidemia
RECRUITINGPhase 2NCT06425341
A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection...
A multicenter, randomized, open, parallel-designed Phase II study to evaluate the efficacy and safety of HRS-5635 injection alone or in combination with other agents in patients...
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Enrolling: 3691 location
Chronic Hepatitis B